It is also important to note that approximately 5–10% of clinically diagnosed multiple endocrine neoplasia type 1 (MEN1) patients have negative genetic test results [75] and that MEN1 has been proposed to predispose individuals to the development of breast cancer [76]. This evidence concerns the gene MEN1 and breast cancer.